Related Experiment Video
Updated: Sep 26, 2025

08:23
Real-time Breath Analysis by Using Secondary Nanoelectrospray Ionization Coupled to High Resolution Mass Spectrometry
Published on: March 9, 2018
9.0K
Development a coordination polymer based nanosensor for phenobarbital determination in exhaled breath condensate
Mehdi Mokhtari1, Elaheh Rahimpour2, Vahid Jouyban-Gharamaleki3
1Pharmaceutical Analysis Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
Journal of Pharmaceutical and Biomedical Analysis
|April 16, 2022
Summary
A new fluorometric probe using luminol-terbium coordination polymer nanoparticles quantifies phenobarbital in mechanical ventilator exhaled breath condensate. This method offers a sensitive and reliable way to monitor drug levels in preterm infants.
Area of Science:
- Analytical Chemistry
- Nanomaterials Science
- Clinical Diagnostics
Background:
- Phenobarbital is a crucial medication for preterm infants, but monitoring its levels in exhaled breath condensate (MVEBC) is challenging.
- Existing methods for phenobarbital quantification may lack sensitivity or require complex sample preparation.
- Developing a rapid and accurate method for MVEBC analysis is essential for optimizing therapeutic outcomes.
Purpose of the Study:
- To develop and validate a novel fluorometric probe for the sensitive quantification of phenobarbital in MVEBC.
- To utilize luminol-terbium coordination polymer nanoparticles (luminol-Tb CP NPs) for enhanced fluorescence detection.
- To establish a reliable method for monitoring phenobarbital in mechanically ventilated preterm neonates.
Main Methods:
- Synthesis and characterization of luminol-terbium coordination polymer nanoparticles (luminol-Tb CP NPs).
- Validation of the fluorometric probe based on aggregation-induced fluorescence enhancement upon phenobarbital coordination.
- Determination of phenobarbital concentration in MVEBC samples from preterm infants using the developed probe.
Main Results:
- The luminol-Tb CP NPs probe demonstrated an aggregation-induced fluorescence enhancement mechanism.
- A linear relationship was observed between fluorescence intensity and phenobarbital concentration in the range of 0.1-10.0 mg.L⁻¹.
- The method achieved a low limit of detection (0.024 mg.L⁻¹) and a good relative standard deviation (3.6%).
Conclusions:
- The developed fluorometric probe offers a sensitive, accurate, and efficient method for phenobarbital quantification in MVEBC.
- This technique holds significant potential for therapeutic drug monitoring in mechanically ventilated preterm neonates.
- The use of luminol-Tb CP NPs provides a promising platform for developing advanced diagnostic tools.

